10/03/2013
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
São Paulo - starts today ( 2 ) the recruitment of the first 50 volunteers who will receive the Brazilian vaccine against dengue fever , which is being developed by the Butantan Institute , in partnership with the University of São Paulo ( USP ) . As was disclosed by the Brazil Thursday ( 26 ) , this first phase of testing will be volunteers from the state capital , and all healthy adults who never had dengue , aged between 18 and 59 years , of both sexes . They will be immunized in two doses with an interval of six months between them .
The vaccine is being developed to combat , in a single dose , four types of disease have been identified worldwide. The technique uses the so-called attenuated . This ignifica the dengue virus itself is modified so that it is able to make people produce antibodies but without developing the disease .
The creation of the vaccine began in 2006 , along with the National Institutes of Health in the United States . Viruses were identified in the country , and subsequently transferred to the Butantan in 2010 .
Scientists have tested the vaccine in more than 600 Americans and revealed no major side effects , only pain and redness at the injection site , feeling common to vaccines .
However , as the United States is not a region where dengue is endemic , any volunteer who received immunization had contracted the disease before . In Brazil , the tests will also involve people who have had dengue.
Those interested in participating in the study can call the phone (11) 2661-7214 and (11) 2661-3344 , or send an email to vacinadengue@usp.br . The next step, which should begin next year , will include people with a history of dengue , and the vaccine will be given in a single dose . 250 volunteers will be the capital city and the city of Ribeirão Preto, in the state .
In the third and final phase will be recruited people from various parts of the country , of various ages . The prediction of the researchers is that the vaccine reaches the population in five years.
Source : Jb Online
Our news are taken in full from our partner sites . For this reason , we can not change the contents of the same even in cases of typos .
transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.